Sterile drugs are susceptible to microbial contamination and so the water used to make their ingredients need to be clean. An Indian API maker has been given that message loud and clear in a warning ...

The roll-up in contract manufacturing continues. Italy’s P&R Group has added a Milan-based CMO to its active pharmaceutical ingredient business. P&R, which is also based in Milan, said last week that ...

The contract research and manufacturing firm Albany Molecular Research Inc. has acquired Gadea Pharmaceutical, a Spanish maker of active pharmaceutical ingredients (APIs) and finished drugs, for $174 ...

An arm of the private equity firm TPG will invest $30 million in Solara Active Pharma, a maker of active pharmaceutical ingredients (APIs). Solara has five manufacturing sites and two research centers ...